Orionis is a clinical-stage life sciences company pioneering the development of novel precision medicines, focusing on cancer therapies through innovative drug modalities such as molecular glues, cytokines, and cell engagers
Orionis is a clinical-stage life sciences company pioneering the development of novel precision medicines, focusing on cancer therapies through innovative drug modalities such as molecular glues, cytokines, and cell engagers.